Title |
Shenhuang granule in the treatment of severe coronavirus disease 2019 (COVID-19): study protocol for an open-label randomized controlled clinical trial
|
---|---|
Published in |
Trials, June 2020
|
DOI | 10.1186/s13063-020-04498-6 |
Pubmed ID | |
Authors |
Bangjiang Fang, Wen Zhang, Xinxin Wu, Tingrong Huang, Huacheng Li, You Zheng, Jinhua Che, Shuting Sun, Chao Jiang, Shuang Zhou, Jun Feng |
X Demographics
The data shown below were collected from the profiles of 2 X users who shared this research output. Click here to find out more about how the information was compiled.
Geographical breakdown
Country | Count | As % |
---|---|---|
United States | 2 | 100% |
Demographic breakdown
Type | Count | As % |
---|---|---|
Members of the public | 2 | 100% |
Mendeley readers
The data shown below were compiled from readership statistics for 140 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Geographical breakdown
Country | Count | As % |
---|---|---|
Unknown | 140 | 100% |
Demographic breakdown
Readers by professional status | Count | As % |
---|---|---|
Student > Bachelor | 18 | 13% |
Other | 12 | 9% |
Student > Ph. D. Student | 11 | 8% |
Researcher | 10 | 7% |
Student > Master | 10 | 7% |
Other | 30 | 21% |
Unknown | 49 | 35% |
Readers by discipline | Count | As % |
---|---|---|
Medicine and Dentistry | 31 | 22% |
Nursing and Health Professions | 18 | 13% |
Pharmacology, Toxicology and Pharmaceutical Science | 7 | 5% |
Psychology | 6 | 4% |
Biochemistry, Genetics and Molecular Biology | 4 | 3% |
Other | 18 | 13% |
Unknown | 56 | 40% |